News:   •  Restaurants   •  Library Catalog   •  Library Activities  •  History   •  Facebook / X/Twitter / RSS

Monrovia's Xencor Reports $32.8 Million Third Quarter Loss

Monrovia's Xencor Inc. has  reported a $32.8 million loss in its third quarter, or a loss of 55 cents per share. The company develops "engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases."

- Brad Haugaard

No comments:

Post a Comment